Fatty Liver in Hormone Receptor-Positive Breast Cancer and Its Impact on Patient's Survival.
Kartika Widayati Taroeno-HariadiYasjudan Rastrama PutraLina ChoridahIrianiwati WidodoMardiah Suci HardiantiTeguh AryandonoPublished in: Journal of breast cancer (2021)
The development of NAFLD during treatment in patients with HR+/HER2- breast cancer was associated with several independent risk factors: being overweight, waist circumference, triglycerides, and LDL-C. Interestingly, breast cancer patients with NAFLD during treatment had longer DFS than those without NAFLD.